title: Antiplatelet therapy for every diabetic person?
authors.affiliation: Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Santa Maria Imbaro (CH), Italy. nicolucci@negrisud.it
authors.forename: Antonio
authors.initials: A
authors.lastname: Nicolucci
authors.forename: Eberhard
authors.initials: E
authors.lastname: Standl
mesh_terms: D001241:Aspirin / Q000009:adverse effects* / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin